Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study.

Wilkie M. et al, (2022), Scientific reports, 12

Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014-2018: A cohort study.

Nyamwaya DK. et al, (2022), PLoS medicine, 19

Sero-prevalence of 19 infectious pathogens and associated factors among middle-aged and elderly Chinese adults: a cross-sectional study.

Yao P. et al, (2022), BMJ open, 12

Comparison of two T cell assays to evaluate T cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers.

Phillips E. et al, (2022), Clinical and experimental immunology

Shared sugars - parasite glycan homology in HIV-1 vaccine design.

Deimel LP. and Sattentau QJ., (2022), Trends in parasitology

Reconstructing the history of helminth prevalence in the UK

Ryan H. et al, (2022), PLOS Neglected Tropical Diseases, 16, e0010312 - e0010312

Long-lasting insecticide-treated net use and malaria infections on the Kenyan coast

Kamau A. et al, (2022), Transactions of The Royal Society of Tropical Medicine and Hygiene

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?

Dockrell HM. and McShane H., (2022), EBioMedicine, 79

An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status

Lumley SF. et al, (2022), Clinical Infectious Diseases, 74, 1208 - 1219

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

Ogbe A. et al, (2022), JCI Insight, 7

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

Närhi F. et al, (2022), The Lancet Digital Health, 4, e220 - e234

Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK.

Cicconi P. et al, (2022), HIV Med, 23, 390 - 396

RIP2-deficiency induces inflammation in response to SV40 Large T induced genotoxic stress through altered ROS homeostasis

Kapplusch F. et al, (2022), Clinical Immunology, 108998 - 108998

National rates and disparities in childhood vaccination and vaccine-preventable disease during the COVID-19 pandemic: English sentinel network retrospective database study.

Hoang U. et al, (2022), Archives of disease in childhood

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.

Killingley B. et al, (2022), Nat Med

SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients.

Shankar S. et al, (2022), Journal of the American Society of Nephrology : JASN

Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity.

Li D. et al, (2022), Commun Biol, 5

Challenges in Developing a Controlled Human Tuberculosis Challenge Model.

Jackson S. and McShane H., (2022), Curr Top Microbiol Immunol

Vitamin D Deficiency and Its Association with Iron Deficiency in African Children

Mogire RM. et al, (2022), Nutrients, 14, 1372 - 1372

A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cells.

Sampson O. et al, (2022), J Immunol Methods, 504

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?